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ABSTRACT 
 
Proteins must be translocated from ribosomes where they are synthesized to 
different cellular destinations where they perform their functions. Many different protein 
translocation systems carry out this activity like the human nuclear pore complex and the 
bacterial Sec and Tat machineries. In Escherichia coli, twin arginine translocation (Tat) 
system is used to transport fully folded proteins across the bacterial cytoplasmic 
membrane and the thylakoid membrane in plants without collapsing the ion gradients. A 
minimal Tat system consists of 3 integral membrane proteins: TatA, TatB and TatC. 
TatB and TatC form a receptor complex for the signal peptide of substrates. In the 
presence of a proton motive force and substrate, TatA is recruited to form the conducting 
channel allowing the mature domain of the substrate to migrate through it. After 
transport, TatA disassembles from the TatBC complex. Biochemical and biophysical 
work has provided information about the mechanism of Tat transport, however, the 
details of the mechanism are poorly understood. Therefore, we want to develop an in 
vitro transport assay at single vesicle level to characterize the sub-steps of Tat 
mechanism at the single vesicle level using total internal reflection fluorescence (TIRF) 
microscopy. 
In vitro bulk experiments showed that the transport assay could be conducted at 
room temperature, which simplifies the assay under microscope by avoiding the 
temperature-control device. Additionally, ATP could replace NADH to generate PMF, 
which could maintain a longer membrane potential. 1.5% PVP could replace BSA to 
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avoid background fluorescence. Vesicles could be tethered on the coverslip surface by 
biotin-streptavidin linkage. Last, the pre-SufI with unnatural amino acid mutation in the 
signal peptide and cysteine mutation in the mature domain could not be labeled with 
Azide-Alexa647 and Alexa568 at the same time. In total, these results laid foundation 
for the in vitro transport assay at the single vesicle level.  
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NOMENCLATURE 
 
∆ψ electric field gradient 
BSA bovine serum albumin 
FRET fluorescence resonance energy transfer 
IMVs inner-membrane vesicles 
NADH beta-Nicotinamide adenine dinucleotide, reduced 
PMF proton motive force 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
SIGNIFICANCE 
Biological and Medical Significance-Importance for Bacterial Growth and Human 
Health 
Bacteria and archaea utilize two general export systems to translocate proteins 
across the cytoplasmic membrane to the periplasm. Sec-machinery mediated secretion is 
an essential pathway that provides for the transport of most proteins in an unfolded state 
and therefore is indispensable for bacterial growth. Tat system transports fully-folded 
and assembled proteins. The absence of a functional Tat system in bacteria often leads to 
growth defects and occasionally death. For example, the Tat system is essential for the 
growth of Mycobacterium tuberculosis (Mtb) (Saint-Joanis et al., 2006). Some Tat 
substrates are involved in the adaption of bacteria to a particular environment or play a 
role in virulence and the absence of a functional Tat system often leads to growth defects 
(Ochsner et al., 2002). For example, the enterohaemorrhagic E. coli serotype O157:H7 
producing Shiga toxin is responsible for haemorrhagic colitis and haemolytic-uremic 
syndrome. A tatABC mutant (TatABC deleted) showed a fivefold decreased secretion of 
this toxin, an important virulence factor of E. coli O157:H7 and became less infectious 
(Pradel et al., 2003). Therefore, knowing the mechanism of the Tat system will help 
future studies on bacterial pathogenesis. Because the Tat pathway is conserved among 
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important bacterial pathogens and absent from mammalian cells, it could be a target for 
novel antimicrobial compounds against human and livestock pathogens. 
Mechanistic Significance-Importance to This Field 
To obtain insight into protein translocation mechanisms, the cargo is often 
trapped in the middle of the translocation process. The resultant structures are then 
analyzed by various techniques. However, up to now, no one in Tat field has 
successfully made Tat middle-state complexes. Several reasons hindered the process to 
understand the Tat mechanism, in particular, the later stages of transport. The 
fundamental problems attributes to the size, membranous nature, transience, low stability, 
and probable conformational and compositional heterogeneity of the translocation 
complex. Instead of trapping intermediates during transport, my goal is to examine the 
dynamics of various sub-steps of Tat translocation cycle in real-time at the single vesicle 
level. This study will clarify some sub-steps of Tat transport. In specific aim 1, we will 
develop an in vitro Tat transport assay at the single vesicle level. Ensemble fluorescence 
experiments are fundamentally limited by averaging and reaction synchrony issues. 
However, single molecule approaches eliminate these concerns and provide valuable 
information about the mechanism. In specific aim 2, we will characterize the kinetics of 
sub-steps of the Tat translocation process to distinguish between different models. The 
ultimate goal is to develop a detailed model of the sequence of events necessary for 
cargo transport.  
 
 
 3 
 
BACKGROUND  
General Secretion Systems 
The Tat pathway functions in the bacterial plasma membrane and plant thylakoid 
membrane to transport proteins to the periplasm and thylakoid lumen, respectively 
(Barrett et al., 2007; Wickner and Schekman, 2005). The system is unusual among 
protein translocators because the substrates are translocated in a fully folded state. In 
parallel, the well-characterized Sec pathway translocates substrates in an unfolded state. 
The Sec and Tat pathways also differ in the energy usage during the translocation. The 
Sec machinery requires ATP hydrolysis and the proton motive force (PMF) while the 
Tat machinery instead depends solely on the PMF. Tat signal peptides are characterized 
by a RRXFLK consensus motif, which includes the twin-arginine (RR-motif) namesake 
(‘Tat’, for ‘twin-arginine translocation’)(Berks, 1996; Sargent et al., 1998). The Tat 
pathway plays key roles in many cellular processes, including photosynthetic and 
respiratory energy metabolism, nitrogen fixation, cell division, resistance to heavy 
metals and antimicrobial peptides, cell motility and virulence (Berks et al., 2003).   
Tat Pathway Components 
In E. coli, the minimal components required for Tat-dependent translocation 
consists of TatA, TatB and TatC (Sargent et al., 1998). TatA and TatB are homologous 
proteins and have similar core structures in which a short hydrophobic N-terminal helix 
is arranged approximately at right angles to an amphipathic helix (APH) and a highly 
charged, natively unstructured tail at the C-terminus. TatC, the largest and most 
conserved of the three Tat components, possesses 6 transmembrane helixes (TMHs), 
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which create a structure that resembles a cupped hand or glove. TatB proteins form 
constitutive, equimolar complexes with TatC, whereas TatA proteins oligomerize and 
increase their association with TatC in response to substrate binding to TatC to form the 
substrate mature domain transducing tunnel.  
Tat Transport Mechanism 
Unraveling the mechanisms of the Tat operation has been challenging because of 
the ephemeral nature of the translocase (Mori and Cline, 2002). However, the basic 
characteristics of the Tat translocation cycle have been experimentally determined using 
isolated pea thylakoids or E. coli inner-membrane vesicles (Fig 1). Firstly, Tat transport 
is initiated when the signal peptide of a substrate protein is recognized and bound by a 
multisubunit TatBC complex located in the membrane (Alami et al., 2003; Cline and 
Mori, 2001). Secondly, the binding of the signal peptide of the substrate to the TatBC 
receptor complex event triggers the PMF-dependent recruitment and oligomerization of 
TatA protomers from a pool in the membrane to form the active TatABC-containing 
translocation site. Thirdly, transport of the folded substrates across the lipid bilayer is 
assumed to be mediated by the assembled TatA oligomer. After completion of the 
transport, the substrate is released from the translocation site, the signal peptide is 
cleaved from the substrate mature domain by the signal peptidase (Luke et al., 2009; 
Yahr and Wickner, 2001), and the translocation site disassembles(Mori and Cline, 2002).  
How the Substrate Mature Domain Migrates Across the Bilayer is Unclear. Two general 
‘pore models’ have been proposed. One states that TatA subunits line up to form 
substrate size-fitting channels (Gohlke et al., 2005; Sargent et al., 2006) based on the 
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observation that channel-like TatA structures of varying diameters are extracted from 
detergent treated non-transporting membranes(Gohlke et al., 2005). Such channels might 
be formed by ‘charge zippers’ from between the amphipathic helix and C-terminal 
densely charged region of TatA, and these insert into the membrane forming a 
hydrophilic TatA channel (Walther et al., 2013). The lipids remains within the pore and 
would diffuse away from the membrane, or, more likely, escape laterally into the 
membrane bilayer as the pore nears completion.  
A popular alternative to the channel model proposes that Tat transport may work 
by weakening the membrane where the TatA molecules are concentrated (Walther et al., 
2013). Substrate transport occur through transient bilayer rupture or once mechanical 
force has been exerted on the substrate to drive it through the weakened bilayer, in the 
meanwhile, the membrane remains intact and impermeable to ions, except at the moment 
of transport. The cell may tolerate the brief ion leakage that occurs during this transient 
opening of the bilayer. The lateral membrane pressure might cause the disordered 
phospholipids to pack around the substrates as it moves through the membrane. 
Evidence shows that Tat transport is strongly influenced by the membrane phospholipid 
composition, which is consistent with a mechanism involving protein-phospholipid 
interactions (Ma and Browse, 2006; Mikhaleva et al., 1999; Sikdar and Doerrler, 2010). 
Possible mechanisms include the interaction between the TatA APH and the cytoplasmic 
leaflet of the membrane (Bruser and Sanders, 2003; Greene et al., 2007) or the mismatch 
between the length of TatA TMH and the width of the bilayer (Rodriguez et al., 2013). 
MD simulations of the detergent-solubilized TatA oligomer structure into membrane 
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suggest that the mismatch mechanism might enable locally thinning the bilayer by about 
80%, with the phospholipids in the thinned membrane showing high disorder (Rodriguez 
et al., 2013). 
  
Fig 1. The cycle of E.coli Tat Transport in the channel model. TatB and TatC form the receptor 
complex, and TatA oligomerizes to form the translocation pore. The substrate binds to the 
membrane surface (B) in addition to the TatBC complex (C). (C-E) The transport processes. 
After transport, signal peptide cleavage occurs releasing the mature protein (F).  
 
The Oligomerization State of TatBC Complex Remains Uncertain  
Numerous studies have verified the stability and 1:1 stoichiometry of the TatBC 
heterodimer (Bolhuis et al., 2001; Maldonado et al., 2011; McDevitt et al., 2006; Orriss 
et al., 2007) but the oligomerization state of TatBC heterodimers remains controversial. 
Various models hypothesize that TatBC is fully functional as a dimer (Maldonado et al., 
2011), trimer (Alcock et al., 2016) or a tetramer (Blummel et al., 2015). However, 
electron microscopy of detergent-solubilized TatBC reveals a ring-shaped structure 
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consistent with an octomer (Tarry et al., 2009). Other oligomers will be considered if 
necessary/warranted. 
The Signal Peptide Binds the Membrane Bilayer Before Binding to the TatBC Complex 
or Not 
Some studies report that a lipid-bound form of the precursor protein is not a 
requisite part of the translocation cycle, and, in fact, is a dead-end intermediate like the 
binding of at least some thylakoid substrates (Bruser and Sanders, 2003; Celedon and 
Cline, 2012). In contrast, other studies show that the precursor protein binds to 
membrane devoid of Tat proteins, suggesting that Tat precursors initially bind to 
membrane lipids and then diffuse to the TatBC complex (Bageshwar et al., 2009; Bruser 
and Sanders, 2003). Another independent study also indicates that the pre-SufI signal 
peptide binds to the phospholipid bilayer of IMVs, but does not penetrate the membrane 
surface in the absence of Tat proteins (Shruthi Hamsanathan, 2017).  
Nevertheless, the mechanism for substrate transport remains very speculative, 
and demands more investigations. Detailed demonstration of substeps of the mechanism 
is still illusive. In order to picture the mechanism elaborately, an in vitro Tat transport 
assay at the single vesicle level will be developed to avoid the averaging and reaction 
synchrony issues (Parks et al., 2017). 
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CHAPTER II 
EXPERIMENTAL DESIGN AND METHODS 
 
QUESTIONS TO ADDRESS 
To Develop an in Vitro Tat Transport Assay at the Single Vesicle Level 
Conventional ensemble experiments have an inherent problem of averaging. In 
contrast, data from measurements in single molecule experiments offer a complete 
description of molecular structure, dynamics and function. In this way, possible 
heterogeneities can be readily identified. These heterogeneities can be either static, when 
various subpopulations of molecules remain unchanged over the observation time or 
dynamic, when there is some interconversion between molecular states during the 
observation time. The discovery of heterogeneities in biomolecular populations opened 
the way for answering important biological questions and also ignited the spark for 
raising new questions about how biological processes are taking place. Therefore, we 
would like to take the challenge to develop an in vitro Tat transport assay at the single 
vesicle level, aiming to provide more specific information about the Tat mechanism. The 
basic design of the real-time transport assay at the single IMV level in vitro will be as 
follows. IMVs will be immobilized on a coverslip, and total internal reflection 
fluorescence (TIRF) microscopy will be used to detect transport sub-steps in real time. A 
home-made flow cell will be used to add and remove reagents. Careful validation of the 
observations will be done to properly interpret the single molecule experiments.  
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Tether the IMVs on the Surface 
To observe in vitro transport at the single vesicle level using TIRF microscopy, 
the vesicles need to be immobilized on a glass slide. The preparation of a surface that 
allows specific immobilization of molecules is one of the most critical steps in the 
single-molecule spectroscopy experiments.  
Immobilization of IMVs on the Coverslip Surface 
A specific immobilization of the vesicles is commonly ensured by biotin. After 
incubation of neutravidin or streptavidin (with its four biotin binding pockets), the 
biotinylated biomolecules can be easily attached to the surface via biotin-avidin linkage. 
The strong biotin-avidin interaction also ensures that the immobilized molecule does not 
detach prematurely and therefore can be monitored for hours. We utilized this method to 
tether vesicles on the coverslip.   
The Effects of Biotinylation of IMVs on in Vitro Transport Efficiency 
Biotin-avidin linkage is planned to be used to stabilize vesicles on the coverslip 
surface. 3-(N-maleimido-propinyl)-biocytin is the reagent used to biotinylate the IMV 
surface through random modification of cysteines in the membrane. Any modification of 
the membrane surface may affect substrate binding and transport across the membrane. 
Here we use TatC-cysteine free version of IMVs to prevent labeling of TatC with MPB. 
Result in preliminary data showed that the MPB modification of IMVs did not affect 
transport. 
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Temperature and Energy Source Effects on the in Vitro Transport 
In general, in vitro transport assay is performed at 37 ℃ , which is the 
physiological temperature of the E. coli. The transport efficiency was determined at 
room temperature. The result showed that the transport efficiency was high enough. This 
definitely simplified the microscope experiments by easier access to flow chamber by 
eliminating the need to install a temperature control device. Due to the scarcity of 
vesicles on the coverslip surface in the planned single molecule experiments and low 
cargo concentrations required to see single molecules, cargos are expected to 
infrequently bind to the IMVs. NADH may not be the ideal source to generate the PMF 
which depends on the dissolution of O2 (Bageshwar and Musser, 2007). The alternative 
will be ATP. It generates a PMF through catalytic reversal of the F0F1 ATPase. With this 
approach, the ∆ψ is independent of the dissolved O2 concentration and depends only on 
the ATP energy charge. Because ATP can be solubilized at higher concentrations than 
O2 and regenerated in situ, the ∆ψ gradient can be maintained for a longer period 
(Bageshwar and Musser, 2007). The result in the preliminary data showed that 
replacement of NADH by ATP wouldn’t affect the transport efficiency.   
Translocation into Coverslip-Adsorbed IMVs at the Single Vesicle Level. 
Coverslip-adsorbed IMVs’ functionality will be determined by the following two 
approaches. First, wild type IMVs (TatABC overexpressed IMVs) will be used. In this 
approach, IMVs will be immobilized on the coverslip surface. Protein translocation can 
be studied on the single vesicle level using precursor proteins labeled with a fluorescent 
fluorophore like pre-SufI. Pre-SufI with Alexa532 maleimide at the mature domain is 
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flowed through the flow cell. After incubating the IMVs and Alexa532 labeled pre-SufI 
for 30 min, I will wash away the unbound substrates. Then I will add NADH or ATP 
will to generate a PMF. The control is without adding either of the two reagents. The 
translocation process will be monitored and read as the accumulation of the Alexa532 
labeled pre-SufI. Finally, 3-carboxy-PROXYL (3-CP) will be added to see whether the 
accumulation is resistant to it. 3-CP is a water-soluble, membrane-impermeant nitroxide 
(Yamada et al., 2004). If the accumulation is resistant to 3-CP, it indicates the substrates 
are transported inside the vesicle. If not, it means that the substrates just bind to the 
vesicle membrane. Similarly, urea/salt wash will be used to discriminate the binding or 
translocation. Expected results: Theoretically, without adding NADH or ATP, we see the 
association and dissociation of the substrates to the lipid membrane. It is not resistant to 
the 3-CP. With NADH or ATP, we expect to see the increase of the fluorescent intensity 
per vesicle will be significantly higher since several turnovers of protein translocation 
lead to more accumulation of pre-SufI inside the vesicles. The accumulation is resistant 
to the 3-CP. Similarly, in the binding scenario, the urea/salt wash will decrease the 
fluorescence in the IMV. However, if the substrates are transported into the vesicles, the 
wash will not change the fluorescence intensity. 
Second, TatATatB
cherry
TatC IMVs and Alexa488 labeled pre-SufI will be used to 
determine the functionality of coverslip-absorbed IMVs. M-cherry IMVs will be 
immobilized on the coverslip surface. The fluorescent M-cherry will be used to localize 
the vesicles. After incubating the IMVs and Alexa 488 labeled pre-SufI for 30 min, I will 
wash away the unbound substrates. Then, I will generate a PMF with NADH or ATP. 
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The control is without adding either of the two reagents. The translocation or binding 
can be verified by the co-localization of Alexa-488-pre-SufI and m-Cherry excited by 
488 nm and 568 nm lasers individually. This accumulation will be tested by resistance to 
the 3-carboxy-PROXYL (3-CP) or urea/salt. Expected results: Theoretically, without 
adding NADH or ATP, we see the association and dissociation of the substrates to the 
lipid membrane. It is not resistant to the 3-CP. When NADH or ATP is added, the 
increase of the fluorescent intensity per vesicle will be significantly higher. We expect 
that several turnovers of protein translocation lead to more accumulation of pre-SufI 
inside the vesicles. The accumulation is resistant to the 3-CP. Similarly, in the binding 
scenario, the urea/salt wash will decrease the fluorescence in the IMV. However, if the 
substrates are transported into the vesicles, the wash will not change the fluorescence 
intensity. 
To Characterize the Kinetics of Sub-Steps of the Tat Translocation Process to 
Distinguish Between Different Models 
Determine the TatBC Oligomerization State. 
TatATatB
YFP
TatC IMVs will be generated. They will be tethered on the coverslip 
surface by the biotin-streptavidin linkage. Total internal reflection fluorescence (TIRF) 
microscopy will be used to photobleach the single vesicle. The fluorescence decrease 
data are recorded. As the control, the intensity of single YFP will be obtained from the 
fluorescence proteins. Analyze the fluorescence bleaching data of IMV with the single 
protein fluorescence intensity; I will know the copy number of TatB. Since the ratio of 
TatB and TatC is 1:1, the TatBC oligomerization state will be determined. Expected 
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results: Ideally, we could get the step-wise photobleaching at single vesicle (Fig 2). The 
observed distribution of photobleaching steps gives the likelihood of detecting a certain 
number of TatB or TatC within a single vesicle and we expect to see that the number of 
TatB or TatC in each single vesicle should follow a Poisson distribution with an average 
number of 1 or 2 based on the estimation.           
 
Fig 2 Example of step-wise photobleaching at the single vesicle level. With the time going, step 
number of photobleaching of TatB is counted. Note: the length for each step of intensity may be 
different due to the reason that two M-Cherry molecules are photobleached at the same time for 
example. t1 is the fluorescent time for one M-cherry and t2 is the fluorescent time for another M-
cherry. 
 
Use FRET to Demonstrate if Lipid-Bound Intermediate is Obligatory at Single Vesicle 
Level. 
The layout of a typical objective-based TIRF single-molecule microscope is 
shown in Figure 3. This microscope is designed for excitation of fluorescence at three 
wavelengths. Fluorescence from the sample goes through the Opti Split III image splitter. 
This divides the image into three spectrally distinct components, which are imaged side 
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by side on an electron multiplication CCD (EMCCD) camera. To date, EMCCDs are the 
most suitable detectors for single molecule imaging because of their combination of high 
signal-to-noise with relatively fast readout speeds.  
 
Figure 3 View of a microscope set up for 3-colour single molecule TIRF microscopy. 
 
There is a divergence over whether the lipid-bound intermediate is a dead-end 
state. It is important to discriminate it since multiple aspects of our current transport 
model rely on a lipid-bound intermediate, at least for pre-SufI. We will directly 
determine the on-and off-rates for pre-SufI binding to the TatBC complex in single 
molecule experiments. A pre-SufI molecule that binds to an IMV is readily distinguished 
from a diffusing molecule by the sudden change in translational mobility. We will 
determine this via the labelled substrate-membrane FRET assay. TatATatBTatC-cherry 
IMVs (acceptor) and Alexa532 labeled-pre-SufI at position 29 or 96 (donor) (Whitaker 
et al., 2012) will be used. IMVs will be absorbed in the home-made chamber on the 
coverslip surface. Substrates and other reagents are flowed through the chamber. Total 
internal reflection fluorescence (TIRF) microscopy will be used to detect the binding 
events in real time. The increase and decrease in FRET will indicate association and 
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dissociation, respectively, from the TatBC complex (Fig 4). The two color images 
required to calculate FRET will be obtained by splitting the emission obtained via donor 
excitation onto two halves of an EMCCD camera. To prove the generality of the results, 
TatBC on-and off-rates will be determined for at least one additional precursor protein, 
e.g., spTorA-Alexa532-GFP.  
  
Fig 4 FRET to test the exchange between lipid binding and translocon binding. (A) At stage 1, 
the substrate binds to the membrane. The donor and acceptor (star and dot) are far away apart 
and low FRET signal is observed. At stage 2, the signal peptide is inserted into the TatBC 
complex, the distance between donor and acceptor is small and at this stage, we expect to see 
high FRET signal. Since substrate’s binding to TatBC complex is a reversible process, at the 
stage 3, we see the dissociation between substrate and TatBC complex. Low FRET signal is seen. 
(B) The graph shows kon and koff indicating the association and dissociation of substrate and 
TatBC complex. Note: the time lenghts of kon and koff may be different. 
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FRET to Show When the Signal Peptide of Substrates is Cleaved 
Fluorescence Labeling of Substrate Used in FRET-FRET requires both a donor 
dye and an acceptor dye. Because of the unsuccessful labelling of two fluorophores in 
one protein by the metal protection and labeling method using the cysteine-maleimide 
chemistry (Puljung and Zagotta, 2011), we would like to incorporate an unnatural amino 
acid into the protein and two independent labeling chemistries to get the dually labelled 
substrates. Unnatural amino acid (Uaa) incorporation by amber codon suppression using 
orthogonal aminoacyl-tRNA synthetase (aaRS)–amber suppressor tRNA (tRNACUA) 
pairs has flourished since 1998(Furter, 1998). The basic idea is to incorporate amber stop 
codon and cysteine by site-directed mutagenesis in the signal peptide of pre-SufI and 
mature domain, respectively. Label the protein with Azide-Alexa 647 and Alexa 568 at 
each site. We expect to get the dually labelled protein with the two fluorophores at a 
ratio 1:1. While the preliminary data indicated that after protein purification, the mature 
SufI dominated. To overcome this problem, we have two solutions. First, construct His-
pre-SufI-11Uaa-58C mutant. Since the His tag is attached at the N-terminal of the signal 
peptide, only proteins with the signal peptide will be purified using Ni column. Second, 
Alexa 532 labeled His-TorA-F8C-Cherry will be used as an alternative substrate. 
Therefore, this protein has Alexa532 in the signal peptide and Cherry as the FRET pair. 
Recent progress in our lab indicated that His tag in the N terminal of signal peptide of 
TorA didn’t affect the transport efficiency.         
Labeling Efficiency and Specificity-Labeling efficiencies is evaluated by 
measuring the UV/vis absorbance spectra of the samples. SDS-PAGE of these samples 
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analyzed by fluorophore-imaging and Coomassie-staining indicates that labeling is very 
specific. The specificity of Alexa dye labeling was estimated by a comparison of the 
UV-vis absorbance spectra of the labeled protein with a cysteine-free and unnatural 
amino acid protein.  
Effect of Dye Labeling on Transport Efficiency-In vitro transport assay will be 
done to determine whether the dye labeling will alter the function of pre-SufI across the 
membrane. When we do the labeling, the Azide-Alexa 647, Alexa 568 or Alexa 532 
dyes will be attached to the protein surface, which will to some extent change the charge 
and hydrophobicity properties and further may affect the binding of substrate to the Tat 
translocon. Therefore, the in vitro transport efficiency of dual labeled protein will be 
tested. 
Use FRET to Show When the Signal Peptide of Substrate is Cleaved-The basic 
design is pretty the same as the one in the aim2b but we will use WT vesicles and dually 
labeled pre-SufI as substrate instead. WT vesicles will be tethered on the coverslip 
surface and a flow chamber will be used to add or remove reagents. TIRF will be used to 
detect the FRET in real time. For this dually labeled pre-SufI protein, a decrease in 
donor (Alexa 568) will be observed in the absence of protease. An increase in donor 
(Alexa568) fluorescence will be observed in the presence of protease, consistent with 
loss of FRET, and under transport conditions, consistent with signal peptide cleavage 
after transport (Fig 5).  
 
 
 18 
 
 
 
Fig 5 FRET to test the signal peptide cleavage. Here I use dual labeled pre-SufI to illustrate how 
to use FRET to test the signal peptide cleavage. In stage 1, the substrate pre-SufI binds to 
membrane and may have a configuration to give a low FRET signal. In state 2, the signal peptide 
inserts into the TatBC complex to make the distance between donor and acceptor shorter. A 
strong FRET signal could be observed. In state 3, the mature domain migrates to the cytoplasm 
side to make the distance between donor and acceptor larger. A weak signal may be seen. 4, after 
the cleavage, the distance between donor and acceptor exceeds 10nm and therefore leads to loss 
of FRET signal.  
 
 
 
 
 
 
 
 
 
 
 19 
 
CHAPTER III 
CONCLUSIONS 
 
IN VITRO TRANSPORT AT ROOM TEMPERATURE  
The basics of in vitro transport assay are as follows. Inverted inner membranes 
vesicles (IMVs) are obtained from E.coli cells overexpressing TatABC by French Press 
treatment and sucrose gradient purification. The precursors (cargos) overexpressed and 
purified from E.coli are transported into the IMV lumen at 37℃ in the presence of a 
PMF. A PMF is generated by NADH (a respiratory substrate) or ATP (which generates a 
PMF by reversal of the ATP synthase). Transport is confirmed by protease treatment 
(which digests protein that remains outside the IMVs) and the presence of a lower 
molecular weight band due to signal peptide cleavage (resulting in mature protein) on an 
SDS-PAGE gel. The cargo is visualized on gels by Western blotting or direct in-gel 
fluorescence (for dye-labeled proteins). Our transport efficiencies are typically high (~ 
20-50%, depending on conditions). For comparison, most protein translocation studies 
report translocation efficiencies< 20% (Fig 6A).   
Our lab developed in vitro transport assay with high efficiency (~20-50%). In 
order to simplify in vitro transport assay under microscope by easy access to the flow 
chamber, we tested whether transport was efficient at room temperatures. The assay was 
carried out following standard protocol under 37℃, 22℃ and 30℃ using the natural 
substrate pre-SufI-IAC as the model cargo. Result showed that the transport efficiency 
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under room temperature (22℃) is 83.1% comparable to the efficiency under 37℃ (Fig 
6B).      
 
 
 
 
 
Fig 6. In vitro transport at room temperature test. (A) Schematic of In Vitro Tat Transport Assay. 
For IMVs, the 'cytoplasm' is outside, and Tat cargos (pre-proteins) are transported into the IMV 
lumen. The signal peptide (blue) is separated from the mature domain (red) by signal peptidase 
after transport. Transport is verified using SDS-PAGE by the presence of a protease-protected 
mature protein. (B) Effect of temperature on in vitro Tat transport assays. The gel shows anti-
SufI immunoblot of transport of pre-sufI into IMVs overexpressing TatABC. Transport requires 
NADH to generate the necessary PMF. In the anti-SufI immunoblot, known amounts of pre-SufI 
(lanes 7-8), marked as a percentage of precursor protein added to the transport reactions, allowed 
quantification of the transport efficiency. Samples were treated by protease K for 42 min at 37℃
(lane 1-2), 22℃(lane 3-4) and 30℃(land 5-6) respectively. Efficient transport occurred under 
different temperatures. [pre-SufI]=90nM; [IMV]=5(A280). 
 
ENERGY SOURCE AND BLOCKING AGENT  
Then, I wanted to test whether NADH could be replaced by ATP. NADH is 
normally used to generate a PMF. ATP was used since we wanted the PMF can be 
A B 
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maintained for a longer period. ATP generates a PMF through catalytic reversal of the 
F0F1 ATPase, which is independent of the dissolved O2 concentration and depends only 
on the ATP energy charge. ATP can be solubilized at higher concentrations than O2 and 
regenerated in situ, the electric field gradient can be maintained for a longer period 
(Bageshwar and Musser, 2007). Result showed that ATP didn’t affect the in vitro 
transport efficiency. 
BSA is used to block the Eppendorf tube in the in vitro transport assay. However, 
BSA may give background fluorescence under microscope. 1.5% PVP was the reagent 
to replace it. PVP didn’t affect the in vitro transport efficiency (Fig7).    
  
 
 
 
 
Fig 7. Effects of ATP and 1.5% PVP on the in vitro transport assays. In this anti-SufI 
immunoblot of transport of pre-sufI into IMVs overexpressing TatABC, lanes 7-8 shows the 
percentage of precursor protein added to the transport reactions, allowing quantification of the 
transport efficiency. Compared to 4 mM NADH to generate the PMF (lane 1-2), 1 mM ATP 
does not affect the transport efficiency (lanes 3-4). 1.5% PVP instead of 10 mg/ml BSA to coat 
the Eppendorf tube didn’t affect the transport efficiency (lanes 5-6). [pre-SufI]=90nM; 
[IMV]=5(A280). 
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BIOTINLATION OF IMVs  
Inverted membrane vesicles (IMVs) from E. coli were isolated and labeled with 
Alexa568. Alexa568 was used because it also has the maleimide-reacting group. MPB 
contains two groups:  maleimide and biotin. Maleimide was used to label the exposed 
cysteines in the membrane to generate the biotinylated IMVs. If IMVs can be labeled 
with Alexa568, it meant that it can be labeled with MPB. At the Alexa568 concentration 
of 2uM, we saw observable labeling of IMVs. Increasing the concentration, more 
labeling was seen (Fig 8A). We next tested the transport efficiency of pre-SufI into MPB 
labeled IMVs since biotin modification on the membrane may alter the efficiency. 
Alexa568-pre-SufI was used as the substrate. We found that this modification didn’t 
affect the transport efficiency (Fig 8B). In order to observe in vitro transport at the single 
vesicle level on the coverslip under a microscope, we need to tether the vesicles on the 
coverslip since transport events can’t be observed when the IMVs are moving in the 
solution. To achieve this, 50uL 0.2mg/mL streptavidin in water was loaded on the 
surface of coverslip, allowed to sit for at least 60min, then washed away with 300uL 
H2O. Biotinylated IMVs at 0.1OD were applied to the chamber. Biotin-streptavidin 
linkage was expected to form and IMVs were tethered on the surface. The IMVs were 
visualized by Nile-red, a dye to stain the neutral lipid in the membrane. Results showed 
that vesicles were only stabilized on streptavidin coated surface (Fig 8C) . 
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Fig 8. Effect of MPB on in vitro transport efficiency of Alexa568-pre-SufI and tethering of 
IMVs on the coverslip surface.  
MPB (3-(N-Maleimidopropionyl)-biocytin) and Alexa568 have the same maleimide-reacting 
group. Alexa568 was used to show that random proteins with cysteines in the membrane of 
vesicles can be labeled with maleimide. The gel in this figure is visualized by fluorescence 
emission upon laser 555 excitation. At 2uM Alexa568, observable labeling of IMVs was seen. 
Increasing concentration of Alexa568 leaded to stronger labeling of IMVs. Red and purple boxes 
show maleimide group and biocytin group respectively. (B) The gel in this figure is visualized 
by fluorescence emission upon laser 555 excitation. Lanes 1-2 shows the percentage of precursor 
protein added to the transport reactions, allowing quantification of the transport efficiency. IMVs 
without MPB labeling were taken as control (lane5-6). Compared to the control, IMVs with 
MPB labeling didn’t show decreased in vitro transport efficiency of Alexa568-pre-SufI. (C) 
Tethering of IMVs on the coverslip surface. Coverslip surface wasn’t coated with streptavidin. 
Biotin-labeled IMVs weren’t tethered on the coverslip surface (Left). Note: the fluorescence dots 
in the image didn’t indicate that the IMVs were tethered on the coverslip surface while it is one 
image from a moive. In contrast, coverslip was coated with 0.2mg/mL streptavidin. Biotin-
labeled IMVs were tethered on the coverslip surface (Right).    
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DOUBLE LABELING OF PRE-SUFI 
In order to get the substrates for FRET with donor and acceptor at the same 
protein, the 11A in the signal peptide and 58S were mutated to unnatural amino acid and 
cysteine through site directed mutagenesis, respectively. The A11Uaa (unnatural amino 
acid) was labeled with Azide-Alexa647 by the copper (I)-catalyzed alkyne-azide 
cycloaddition (CuAAC) reaction. Copper(I)-Catalyzed Azide-Alkyne Cycloaddition 
(CuAAC) forms a 1,4-disubstituted-1,2,3-triazole by an azide and a terminal alkyne 
when in the presence of a copper(I) catalyst and copper(I)-binding ligand. The S58C was 
labeled with Alexa568 through maleimide-thiol reaction. At the very beginning, we 
tested whether the two dyes could label the pre-SufI at the same time. If this occurred, 
time would be saved. Therefore, the pre-SufI was reduced by copper and then incubated 
with both dyes. Results showed that copper reduced the Alexa568 maleimide labeling in 
the mature domain of pre-SufI and therefore we couldn’t label pre-SufI with the two 
dyes at the same time (Fig 9A). Noticeably, the Azide-Alexa647 band always has a 
higher molecule weight than the Alexa568 band but ideally the two bands should overlap 
together. Since Alexa647 only labels protein with signal peptide, we suspected that the 
purified protein was predominantly mature SufI. This likely occurred for 2 reasons. 
Firstly, unnatural amino acids typically lower the yield of proteins since they have to 
compete with the release factor. Secondly, the signal peptide of pre-SufI was cut off by 
cytoplasmic peptidase, a problem which is particularly acute when the expression level 
was low. In order to confirm our guess, we run two single cysteine mutants of pre-SufI 
as controls in parallel with pre-SufI-58C-11-Uaa. The results showed that for the 
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controls, although there were some mature forms of SufI, the pre-SufI dominated. While 
for the pre-SufI-58C-11-Uaa, we barely saw the precursor form of pre-SufI (Fig 9B).       
 
 
 
Fig 9. Labeling of pre-SufI with Azide-Alexa647 and Alexa568. (A) The gel in this figure is 
visualized by fluorescence emission upon laser 555 and 647 excitation. Coomassie blot showed 
equal loading amount. Pre-SufI is labeled with Azide-Alexa647 in the signal peptide and 
Alexa568 in the mature domain lane1-2). Only in the presence of copper (+), pre-SufI was 
labeled by Azide-Alexa647. As to Alexa568, copper decreased pre-SufI labeling (lane 1 and 2). 
Lane 3 and 4 showed pre-SufI was labeled with Azide-Alexa 647. It indicated that the Azide-
Alexa647 is only labeled in the presence of copper. Lane 5 and lane 6 showed that pre-SufI was 
labeled with Alexa 568. It indicated that copper decreased Alexa 568 labeling. However, from 
the pseudo color overlap, Azide-Alexa647 was higher than Alexa568. (B) The right gel was 
visualized by Coomassie staining. It explained why the Azide-Alexa647 band was higher than 
Alexa568. Two single cysteine mutants pre-SufI-21C and pre-SufI-2C (left two lanes) ran 
parallel with the mutant contained cysteine and unnatural amino acid pre-SufI-58C-Uaa (3rd lane 
from left to right). After purification, the mature form of pre-SufI-58C-Uaa occupied mostly. 
This well explained Azide-Alexa647 band was higher than Alexa568. 
A B 
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